The Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund) welcomed a commitment of JPY 350 million from Takeda Pharmaceutical Company, a Japan-based global leader in pharmaceuticals. This marks the first corporate commitment to the Gl...
The Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund) held its 53rd Board meeting last week in Geneva. Amid severe disruptions to health services across countries and growing global health funding uncertainty, discussions on grant...
The Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund) has reached a historic milestone by procuring – for the first time – a first-line HIV treatment manufactured in Africa. The treatment – lifesaving, quality-assured antiretrovir...
In response to the devastating earthquakes that struck central Myanmar on 28 March, the Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund) has approved an emergency funding allocation of US$5 million to support urgent health needs ...
The Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund) today announced the first pledge to its Eighth Replenishment Campaign – and it comes from the private sector. The Children’s Investment Fund Foundation (CIFF) has made a ground...
Under its G20 Presidency, South Africa highlights the urgent need for sustained investment in health systems, vital for the continent and the world’s stability, while the UK remains committed to building modern partnerships able to deliver sustainabl...